Citadel Advisors’s Bruush Oral Care Inc. Common Stock BRSH Stock Holding History

Citadel Advisors’s Portfolio BRSH Stock Details BRSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-446,194	Closed	-$23.4K	–	15751
2024 Q1	$23.4K	Buy	+446,194	New	+$39.7K	﹤0.01%	12896
2023 Q3	–	Sell	-3,310	Closed	-$19.5K	–	15366
2023 Q2	$19.5K	Buy	+3,310	New	+$23.5K	﹤0.01%	12743
2022 Q4	–	Sell	-1,533	Closed	-$39K	–	15615
2022 Q3	$39K	Buy	+1,533	New	+$64.8K	﹤0.01%	11776

Other funds holding BRSH

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Citadel Advisors's BRSH Position: Q2 2024 in Review

Citadel Advisors sold out of Bruush Oral Care Inc. Common Stock (BRSH) in Q2 2024, closing a stake of 446,194 shares — an estimated $23.4K sold.

Citadel Advisors first reported a position in BRSH in Q3 2022 and held it in 3 quarters. The position peaked at $39K in Q3 2022. 2 funds tracked by Wall St. Rank hold BRSH as of Q2 2024.

Citadel Advisors reported no remaining Bruush Oral Care Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Citadel Advisors sold 446,194 Bruush Oral Care Inc. Common Stock shares in Q2 2024, an estimated $23.4K.
Citadel Advisors first reported a position in Bruush Oral Care Inc. Common Stock in Q3 2022 and held it in 3 quarters.
Citadel Advisors's Bruush Oral Care Inc. Common Stock position peaked at $39K in Q3 2022.
2 funds tracked by Wall St. Rank held Bruush Oral Care Inc. Common Stock as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.